Skip to main content

Lithium prophylaxis in major affective disorders: on the specificity and sensitivity of some “new” predictors of treatment outcome

  • Chapter

Abstract

Since the controversy over the long term efficacy of lithium has been definitively overcome with the unequivocal demonstration that lithium is a valuable treatment for both the prevention and the attenuation of affective recurrences in a substantial portion of patients suffering from Major Affective Disorders (MAD) (1, 2, 3), studies with lithium have been focused more and more on attempts to predict which candidates might be expected to have good lithium responses (4, 5, 6, 7). Clinical and experimental needs both require this type of research. First of all, adequate recognition of patients who will respond differently to lithium, not only gives a rational basis for whether or not to undertake long term lithiumstabilization, it also influences investigations of new putative stabiliz-ing treatments (8), since the definition of the risk-benefit ratios of these alternative therapies will weigh differently if they are chiefly indicated for lithium responders or lithium non-responders. Furthermore, the differentiation of lithium responders from lithium non-responders could be of fundamental importance for proper understanding of the basic processes underlying the disease in the different subgroups of MAD.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Prien, R. F. (1979). Clinical use of lithium — Part I: Introduction. In: Cooper, T.B., Gershon, S., Kline, N.S. and Schou, M. (eds). Lithium: Controversies and Unresolved Issues. pp. 3–29. (Amsterdam: Excerpta Medica)

    Google Scholar 

  2. Georgotas, A. and Gershon, S. (1979). Lithium in manic-depressive illness: some highlights and current controversies. In: Cooper, T.B., Gershon, S., Kline, N.S. and Schou, M. (eds). Lithium: Controversies and Unresolved Issues. pp. 57–84. (Amsterdam: Excerpta Medica)

    Google Scholar 

  3. Gerbino, L., Oleshansky, M. and Gershon, S. (1978). Clinical use and mode of action of lithium. In: Lipton, M.A., Di Mascio, A. and Killam, K.F. (eds). Psychophar-macoIogy: A Generation of Progress. pp. 1261–75. (New York: Raven Press)

    Google Scholar 

  4. Carrol, B.J. (1979). Prediction of treatment outcome with lithium. In: Cooper, T.B., Gershon, S., Kline, N.S. and Schou, M. (eds). Lithium: Controversie and Unresolved Issues. pp. 171–97. (Amsterdam: Excerpta Medica)

    Google Scholar 

  5. Frazer, A., Mendels, J., Ramsky, T.A. et al. (1979). Erythrocyte concentrations of the lithium ion. In: Cooper, T.B., Gershon, S., Kline, N.S. and Schou, M. (eds). Lithium: Controversies and Unresolved Issues. pp. 198–208. (Amsterdam: Excerpta Medica)

    Google Scholar 

  6. Cazzullo, C.L., Sacchetti, E. and Smeraldi, E. (1979). Psychotropic drugs and their relationship with psychopatology of affective disorders. Progress in Neuro-psychopharmacol., 3, 25–38

    Article  CAS  Google Scholar 

  7. Cazzullo, C.L., Sacchetti, E. and Smeraldi, E. New trends on long term lithium treatment in affective disorders. In: Cazzullo, C.L. and Invernizzi, G. (eds). Prevention in Psychiatry. (1979). pp. 115–30. (Milano: Edi Ermes)

    Google Scholar 

  8. Emrich, H.M. (1982). Prophylactic therapies in affective disorders: mode of action from a clinical point of view. In: Emrich, H.M., Aldenhoff, J.B. and Lux, H.D. (eds). Basic Mechanisms in the Action of Lithium. pp. 202–14. (Amsterdam: Excerpta Medica)

    Google Scholar 

  9. Post, R.M. and Goodwin, F.K. (1978). Approaches to brain amines in psychiatric patients: a reevaluation of cerebrospinaI fluid studies. In: Iversen, L.L., Iversen S.D. and Snyder, S.H. (eds). Handbook of Psychophar-macoIogy. Biology of Mood and Antianxiety Drugs. pp. 147–85. (New York: Plenum Press)

    Google Scholar 

  10. Goodwin, F.K., Cowdry, R.W. and Webster M.H. (1978). Predictors of drug response in the affective disorders: towards an integrated approach. In: Lipton, M.A., Di Mascio A. and Killam, K.F. (eds). Psychopharmacology: A Generation of Progress. pp. 1277–88. (New York: Raven Press)

    Google Scholar 

  11. van Praag, H.M. (1978). Amine hypothesis of affective disorders. In: Iversen, L.L., Iversen, S.D. and Snyder, S.H. (eds). Handbook of Psychopharmacology. Biology of Mood and Antianxiety Drugs. pp. 187–297. (New York: Plenum Press)

    Google Scholar 

  12. Sacchetti, E. and Smeraldi, E. (1980). MHPG e depres-sione primaria: una rivalutazione delle ipotesi monoaminer-giche tradizionali. In: Smeraldi, E. and Sacchetti, E. (eds). La Depressione come Problema Psicobiologico. pp. 49–79. (Milano: Edi Ermes)

    Google Scholar 

  13. Schatzberg, A.F., Orsulak, P.J., Rosenbaum, A.H. et al. (1983). Biochemical subtypes of unipolar depressives. In: Clayton, P.J. and Barret, J.E. (eds). Treatment of Depression: Old Controversies and New Approaches. pp. 53–9. (New York: Raven Press)

    Google Scholar 

  14. Winokur, G. (1978). Mania and depression: family studies and genetics in relation to treatment. In: Lipton, M.A., Di Mascio, A. and Killam, K.F. (eds). Psychopharmacology: A Generation of Progress. pp. 1213–21. (New York: Raven Press)

    Google Scholar 

  15. Maas, J.W. (ed) (1983). MHPG: Basic Mechanisms and Psychopatology. (New York: Academic Press)

    Google Scholar 

  16. Cazzullo, C.L., Smeraldi, E., Sacchetti, E. and Bottinelli, S. (1975). Intracellularlithium concentration and clinical response. Brit. J. Psychiat., 126, 298–300

    Article  PubMed  CAS  Google Scholar 

  17. Sacchetti, E., Bottinelli, S., Bellodi, L. et al. (1977). Erythrocyte/plasma lithium ratios. Lancet, II, 908

    Article  Google Scholar 

  18. Feighner, J.P., Robins, E., Guze, S. et al. (1972). Diagnostic criteria for use in psychiatric research. Arch.Gen. Psychiatry., 26, 57–63

    Article  PubMed  CAS  Google Scholar 

  19. American Psychiatric Association, Committee on nomenclature and statistics: Diagnostic and Statistical Manual of Mental Disorders, ed. III. (1980) (Washington D.C.: A.P.A.)

    Google Scholar 

  20. Cazzullo, C.L. and Sacchetti, E. Critical issues in the evaluation of long term lithium treatment. In this volume.

    Google Scholar 

  21. Cazzullo, C.L., Sacchetti, E., Allaria, E. et al. (1982). Is urinary MHPG a real predictor of drug response in Primary Depression? In: Costa, E. and Racagni, G. (eds). Typical and Atypical Antidepressants: Clinical Practice, pp. 237–47. (New York: Raven Press)

    Google Scholar 

  22. Beckmann, H. and Goodwin, F.K. (1980). Urinary MHPG in subgroups of depressed patients and normal controls. Neuropsychobiology., 6, 91–100

    Article  PubMed  CAS  Google Scholar 

  23. Sacchetti, E., Allaria, E., Negri, F. et al. (1979). 3-methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations. Biol. Psychiatry., 14, 473–84

    PubMed  CAS  Google Scholar 

  24. Maas, J.K. (1978). Clinical implications of pharmacological differences among antidepressants. In: Lipton, M.A., Di Mascio, A. and Killam, K.F. (eds). Psychopharmacology: A Generation of Progress. pp. 955–60. (New York: Raven Press)

    Google Scholar 

  25. Maas, J.W., Kocsic, J.H., Bowden, C.L. et al. (1982) Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment. Psychological Medicine., 12, 37–43

    Article  PubMed  CAS  Google Scholar 

  26. Sacchetti, E., Faravelli, C., Conte, G. et al. Monoaminergic profiles in major affective disorders and clinical response to long term lithium treatment. A four-to-six years follow up. Submitted for publication.

    Google Scholar 

  27. Angst, J. and Grof, P. (1979). Selection of patients with recurrent affective illness for a long term study: testing research criteria on prospective follow up data. In: Cooper, T.B., Geshon, S., Kline, N.S. and Schou, M. (eds). Lithium: Controversies and Unresolved Issues. pp. 355–69.(Amsterdam: Excerpta Medica)

    Google Scholar 

  28. Zis, A.P., Grof., P. and Goodwin, F.K. (1979). The natural course of affective disorders: implications for lithium prophylaxis. In: Cooper, T.B., Gershon, S., Kline, N.S. and Schou, M. (eds). Lithium: Controversie and Unresolved Issues., pp. 381–98. (Amsterdam: Excerpta Medica)

    Google Scholar 

  29. Omenn, G.S. and Motulsky, A.G. (1975). Pharmacogenetics: clinical and experimental studies in man. In: Eleftheriou, B.E. (ed). Psychopharmacogenetics. pp. 183–228. (New York: Plenum Press)

    Google Scholar 

  30. Faravelli, C., Broadhurst, A., James, H. and Sacchetti, E. (1981). Pharmacokinetic, clinical and biological parameters modulating the response to chlorimipramine. In: Perris, C., Struwe, G. and Jansson, B. (eds). Biological Psychiatry 1981. pp. 1167–70. (Amsterdam: Elsevier/North Holland Biomedical Press)

    Google Scholar 

  31. Sacchetti, E. Depressione primaria: ruolo dell’eterogeneitàbiochimica nella modulazione dell’effetto terapeutico dei sali di litio e dei farmaci antidepressivi. Proceedings of the XXXV Congress of the Italian Society of Psychiatry. In press

    Google Scholar 

  32. Sacchetti, E., Vita, A., Conte, G. et al. Long term lithium effectiveness in major affective disorders: relationship to tricyclic antidepressants responsiveness. In preparation

    Google Scholar 

  33. Buchsbaum, M.S., Maier, R.J. and Murphy, D.L. (1977) Suicide attempts, platelet monoamine oxidase and the average evoked response. Acta Psychiat. Scand., 56, 69–79

    Article  PubMed  CAS  Google Scholar 

  34. Brown, G.L., Goodwin, F.K. and Bunney, W.E. Jr. (1982). Human aggression and suicide: their relationship to neuropsychiatrie diagnoses and serotonin metabolism. In: Ho, B.T., Schoolar, J.C. and Usdin, E. (eds). Serotonin in Biological Psychiatry. pp. 287–307.(New York: Raven Press)

    Google Scholar 

  35. Traskman, L., Āsberg, M., Bertilsson, L. and Sjostrand, L. (1981). Monoamine metabolites in CSF and suicidal behavior. Arch. Gen. Psychiatry., 38, 831–36

    Article  Google Scholar 

  36. Montgomery, S.A. and Montgomery, D.B. (1982). Drug treatment of suicidal behavior. In: Costa, E. and Racagni, G. (eds). Typical and Atypical Antidepressants: Clinical Practice. pp. 347–55.(New York: Raven Press)

    Google Scholar 

  37. Sacchetti, E., Conte, G., Vita, A. et al. Proneness to suicidal behavior in major depressives identifies homogeneous pharmacological patterns. In preparation

    Google Scholar 

  38. van Praag, H.M. (1982). Serotonin precursors in the treatment of depression. In: Ho, B.T., Schoolar, J.C. and Usdin, E. (eds). Serotonin in Biological Psychiatry, pp. 259–86. (New York: Raven Press)

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 MTP Press Limited

About this chapter

Cite this chapter

Sacchetti, E., Vita, A., Conte, G., Pennati, A. (1984). Lithium prophylaxis in major affective disorders: on the specificity and sensitivity of some “new” predictors of treatment outcome. In: Corsini, G.U. (eds) Current Trends in Lithium and Rubidium Therapy. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7318-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-7318-6_13

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-7320-9

  • Online ISBN: 978-94-011-7318-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics